Headwaters Technology Innovation’s (HTI) NxCat™ technology allows catalyst design to take place on the molecular scale. NxCat™ technology enables scientists to control the structure and function of catalyst particles smaller than 10 nm.
HTI, a wholly owned subsidiary of Headwaters Incorporated (NYSE: HW), was established to develop and commercialize business opportunities around the NxCat™ technology platform. HTI is developing strategic partnerships with dynamic companies such as Evonik (EvonikHeadwaters) and Sumitomo Chemical for the development of catalysts and novel nanomaterials.
Research and development work is conducted at the company’s R&D Center located in Lawrenceville, New Jersey.